Sodium and proton coupling in the transport cycle of the neutral amino acids antiporter ASCT2 (SLC1A5)

被引：0
|
作者：
Pochini, Lorena [1 ]
Scalise, Mariafrancesca [1 ]
Mazza, Tiziano [1 ]
Indiveri, Cesare [1 ,2 ]
机构：
[1] Univ Calabria, Unit Biochem Mol Biotechnol & Mol Biol, Dept DiBEST, Arcavacata Di Rende, Cosenza, Italy
[2] Natl Res Council CNR, Inst IBIOM, Bari, Italy
来源：
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS | 2022年 / 1863卷
关键词：
D O I：
10.1016/j.bbabio.2022.148724
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
S5.P8
引用
收藏
页码：43 / 43
页数：1
相关论文
共 50 条
  • [21] ASCT2 (SLC1A5)-dependent glutamine uptake is involved in the progression of head and neck squamous cell carcinoma
    Ze Zhang
    Ruoyan Liu
    Yanjie Shuai
    Yuting Huang
    Rui Jin
    Xudong Wang
    Jingtao Luo
    British Journal of Cancer, 2020, 122 : 82 - 93
  • [22] Asparagine transport through SLC1A5/ASCT2 and SLC38A5/SNAT5 is essential for BCP-ALL cell survival and a potential therapeutic target
    Taurino, Giuseppe
    Dander, Erica
    Chiu, Martina
    Pozzi, Giulia
    Maccari, Chiara
    Starace, Rita
    Silvestri, Daniela
    Griffini, Erika
    Bianchi, Massimiliano G.
    Carubbi, Cecilia
    Andreoli, Roberta
    Mirandola, Prisco
    Valsecchi, Maria Grazia
    Rizzari, Carmelo
    D'Amico, Giovanna
    Bussolati, Ovidio
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (01) : 175 - 188
  • [23] ASCT2 (SLC1A5)-Deficient Mice Have Normal B-cells Developments, proliferation, and Antibody Production
    Masle-Farquhar, Etienne
    Broer, Angelika
    Yabas, Mehmet
    Enders, Anselm
    Broer, Stefan
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [24] Cryo-EM structures of the human glutamine transporter SLC1A5 (ASCT2) in the outward-facing conformation
    Yu, Xiaodi
    Plotnikova, Olga
    Bonin, Paul D.
    Subashi, Timothy A.
    McLellan, Thomas J.
    Dumlao, Darren
    Che, Ye
    Dong, Yin Yao
    Carpenter, Elisabeth P.
    West, Graham M.
    Qiu, Xiayang
    Culp, Jeffrey S.
    Han, Seungil
    ELIFE, 2019, 8
  • [25] Downregulation of LAT1 (SLC7A5) and ASCT2 (SLC1A5) and proliferation of human colon cancer HCT-116 cells.
    Carneiro, C.
    Oliveira, A.
    Serrao, P.
    Kennedy, P.
    Soares-da-Silva, P.
    MOLECULAR BIOLOGY OF THE CELL, 2018, 29 (26)
  • [26] Ligand Discovery for the Alanine-Serine-Cysteine Transporter (ASCT2, SLC1A5) from Homology Modeling and Virtual Screening
    Colas, Claire
    Grewer, Christoph
    Gameiro, Armanda
    Albers, Thomas
    Singh, Kurnvir
    Otte, Nicholas J.
    Shere, Helen
    Massimiliano, Bonomi
    Holst, Jeff
    Schlessinger, Avner
    BIOPHYSICAL JOURNAL, 2015, 108 (02) : 54A - 54A
  • [27] Ligand Discovery for the Alanine-Serine-Cysteine Transporter (ASCT2, SLC1A5) from Homology Modeling and Virtual Screening
    Colas, Claire
    Grewer, Christof
    Otte, Nicholas James
    Gameiro, Armanda
    Albers, Thomas
    Singh, Kurnvir
    Shere, Helen
    Bonomi, Massimiliano
    Holst, Jeff
    Schlessinger, Avner
    PLOS COMPUTATIONAL BIOLOGY, 2015, 11 (10)
  • [28] Deletion of Amino Acid Transporter ASCT2 (SLC1A5) Reveals an Essential Role for Transporters SNAT1 (SLC38A1) and SNAT2 (SLC38A2) to Sustain Glutaminolysis in Cancer Cells
    Broer, Angelika
    Rahimi, Farid
    Broer, Stefan
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (25) : 13194 - 13205
  • [29] ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer
    M van Geldermalsen
    Q Wang
    R Nagarajah
    A D Marshall
    A Thoeng
    D Gao
    W Ritchie
    Y Feng
    C G Bailey
    N Deng
    K Harvey
    J M Beith
    C I Selinger
    S A O'Toole
    J E J Rasko
    J Holst
    Oncogene, 2016, 35 : 3201 - 3208
  • [30] ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer
    van Geldermalsen, M.
    Wang, Q.
    Nagarajah, R.
    Marshall, A. D.
    Thoeng, A.
    Gao, D.
    Ritchie, W.
    Feng, Y.
    Bailey, C. G.
    Deng, N.
    Harvey, K.
    Beith, J. M.
    Selinger, C. I.
    O'Toole, S. A.
    Rasko, J. E. J.
    Holst, J.
    ONCOGENE, 2016, 35 (24) : 3201 - 3208
12345